| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 761.00K | — |
| Operating expense | — | — |
| Net income | -50.22M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DNTH returned +357.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +169.6% |
| 1 year | +357.2% |
| 5 years | +8.5% |
| All-time high | $263.52 (Mar 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DNTH would be worth today ›No. Dianthus Therapeutics, Inc. has not paid a dividend in the past 12 months.
Dianthus Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol DNTH.
Dianthus Therapeutics, Inc. is part of the Healthcare sector.
Dianthus Therapeutics, Inc. has a market cap of 6.21B USD, based on the latest quote.
